Photo of Shoshana M Rosenberg,  ScD, MPH

Shoshana M Rosenberg, ScD, MPH

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Shoshana M Rosenberg, ScD, MPH

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Instructor, Medicine, Harvard Medical School
  • Instructor, Medical Oncology, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Research Abstract

I am a cancer epidemiologist and health services researcher with an interest in the unique issues affecting young women with breast cancer. My research focuses on survivorship, quality of life, and treatment decision-making in this population. I am trained in both quantitative and qualitative research methods and design, conduct, and analyze a wide range of studies. Current projects include exploring why young breast cancer patients are increasingly choosing contralateral prophylactic mastectomy and understanding patterns of endocrine therapy non-initiation, non-adherence, and non-persistence in young women with breast cancer. Additionally, I am involved in designing and incorporating patient-reported outcome measures into therapeutic breast cancer clinical trials.

Publications

Powered by Harvard Catalyst
  • Rosenberg SM, Ligibel JA, Meyerhardt JA, Jacobsen ED, Garber JE, Nekhlyudov L, Bunnell CA, Nutting P, Sprunck-Harrild K, Walsh SK, Partridge AH. Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ 2017. PubMed
  • Rosenberg SM, Gelber S, Gelber RD, Krop E, Korde LA, Pagani O, Partridge AH. Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. J Adolesc Young Adult Oncol 2017. PubMed
  • Rosenberg SM, Partridge AH. Looking back, moving forward: the evolution of cancer survivorship care. Lancet Oncol. 2017; 18:18-19. PubMed
  • Rosenberg SM, King TA. Contralateral prophylactic mastectomy and quality of life: answering the unanswered questions? Gland Surg 2016; 5:261-2. PubMed
  • Walker HE, Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol 2016; 5:16-23. PubMed
  • Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol 2016. PubMed
  • Rosenberg SM, Moskowitz CS, Ford JS, Henderson TO, Frazier AL, Diller LR, Hudson MM, Stanton AL, Chou JF, Smith S, Leisenring WM, Mertens AC, Cox CL, Nathan PC, Krull KR, Robison LL, Oeffinger KC. Health Care Utilization, Lifestyle, and Emotional Factors and Mammography Practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2015. PubMed
  • Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, Winer EP, Partridge AH. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol 2015. PubMed
  • Rosenberg SM, Partridge AH. New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. Journal of the National Cancer Institute 2015. PubMed
  • Rosenberg SM, Newman LA, Partridge AH. Breast Cancer in Young Women: Rare Disease or Public Health Problem? JAMA Oncol 2015; 1:877-8. PubMed
  • Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist 2015; 20:598-604. PubMed
  • Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med 2013; 159:373-81. PubMed
Hide